Travere Therapeutics (TVTX) Other Gross PP&E Adjustments (2015 - 2026)
Travere Therapeutics posted quarterly Other Gross PP&E Adjustments of -$9.7 million for Q1 2026, up 26.74% year-on-year from -$7.6 million in Q1 2025, and up 7.28% on a QoQ basis from -$10.4 million in Q4 2025.
Travere Therapeutics (TVTX) has 12 years of Other Gross PP&E Adjustments data on file, last reported at -$9.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 26.74% year-over-year to -$9.7 million; the trailing twelve-month figure through Mar 2026 stood at -$9.7 million (up 26.74% YoY), and the FY2025 full-year result was -$10.4 million, up 34.36% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$9.7 million, up from -$10.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$9.7 million in Q1 2026 and bottomed at -$29.7 million in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$17.3 million (2024), against an average of -$17.7 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments slipped 9.79%; it then jumped 35.81% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$29.7 million in 2022, then gained by 16.66% to -$24.7 million in 2023, then soared by 35.81% to -$15.9 million in 2024, then surged by 34.36% to -$10.4 million in 2025, then gained by 7.28% to -$9.7 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$9.7 million (Q1 2026), -$10.4 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | -9.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.67 Mn |
| Mar 31, 2026 | -9.67 Mn |
| Dec 31, 2025 | -10.43 Mn |
| Dec 31, 2025 | -10.43 Mn |
| Sep 30, 2025 | -11.46 Mn |
| Sep 30, 2025 | -11.46 Mn |
| Jun 30, 2025 | -12.34 Mn |
| Jun 30, 2025 | -12.34 Mn |
| Mar 31, 2025 | -13.20 Mn |
| Mar 31, 2025 | -13.20 Mn |
| Dec 31, 2024 | -15.88 Mn |
| Dec 31, 2024 | -15.88 Mn |
| Sep 30, 2024 | -15.66 Mn |
| Sep 30, 2024 | -15.66 Mn |
| Jun 30, 2024 | -16.47 Mn |
| Jun 30, 2024 | -16.47 Mn |
| Mar 31, 2024 | -17.27 Mn |
| Mar 31, 2024 | -17.27 Mn |
| Dec 31, 2023 | -24.75 Mn |
| Dec 31, 2023 | -24.75 Mn |
| Sep 30, 2023 | -18.81 Mn |
| Sep 30, 2023 | -18.81 Mn |
| Jun 30, 2023 | -19.56 Mn |
| Jun 30, 2023 | -19.56 Mn |
| Mar 31, 2023 | -20.29 Mn |
| Mar 31, 2023 | -20.29 Mn |
| Dec 31, 2022 | -29.69 Mn |
| Dec 31, 2022 | -29.69 Mn |
| Sep 30, 2022 | -21.25 Mn |
| Sep 30, 2022 | -21.25 Mn |
| Jun 30, 2022 | -21.91 Mn |
| Jun 30, 2022 | -21.91 Mn |
| Mar 31, 2022 | -22.56 Mn |
| Mar 31, 2022 | -22.56 Mn |
| Dec 31, 2021 | -27.05 Mn |
| Dec 31, 2021 | -27.05 Mn |
| Sep 30, 2021 | -23.80 Mn |
| Sep 30, 2021 | -23.80 Mn |
| Jun 30, 2021 | -24.40 Mn |
| Jun 30, 2021 | -24.40 Mn |
| Mar 31, 2021 | -25.00 Mn |
| Mar 31, 2021 | -25.00 Mn |
| Dec 31, 2020 | -43.13 Mn |
| Dec 31, 2020 | -43.13 Mn |
| Sep 30, 2020 | -34.60 Mn |
| Sep 30, 2020 | -34.60 Mn |
| Jun 30, 2020 | -34.60 Mn |
| Jun 30, 2020 | -34.60 Mn |
| Dec 31, 2019 | -14.73 Mn |
| Dec 31, 2019 | -14.73 Mn |
| Sep 30, 2019 | -7.35 Mn |
| Sep 30, 2019 | -7.35 Mn |
| Jun 30, 2019 | -7.60 Mn |
| Jun 30, 2019 | -7.60 Mn |
| Mar 31, 2019 | -8.61 Mn |
| Mar 31, 2019 | -8.61 Mn |
| Dec 31, 2018 | -12.48 Mn |
| Dec 31, 2018 | -12.48 Mn |
| Dec 31, 2017 | -11.88 Mn |
| Dec 31, 2017 | -11.88 Mn |
| Dec 31, 2016 | -15.73 Mn |
| Dec 31, 2016 | -15.73 Mn |
| Dec 31, 2015 | -9.48 Mn |
| Dec 31, 2015 | -9.48 Mn |